Skill Profile
Formulary Management
"The observable action of evaluating, selecting, and maintaining a medicines formulary — reviewing clinical evidence, cost-effectiveness data, and safety profiles for drug candidates, facilitating medicines management committee decisions, and monitoring formulary adherence — in order to ensure that an organisation's approved medicines list is clinically appropriate, cost-effective, and safe for the patient population it serves."
YOUR SKILLS
Problems This Skill Solves
- Irrational or unsafe prescribing variation — without a managed formulary, prescribers in a health system may choose from thousands of available medicines without clinical governance oversight, creating inconsistency, safety risks, and avoidable cost
- NHS medicines budget pressure — formulary management with NICE technology appraisal implementation and generic substitution policies ensures that cost-effective medicines are used as first-line treatments, releasing budget for high-value innovations
- Patient safety risks from polypharmacy and unlicensed medicines — formulary review processes evaluate drug interactions, contraindication profiles, and licensing status, creating an organisational guardrail against unsafe prescribing
- Prescribing inertia when superior evidence emerges — formularies provide the mechanism to mandate adoption of new NICE-approved treatments and phase out superseded or withdrawn medicines across a health system
Tools Used
"Formularies restrict clinical freedom — doctors should be able to prescribe whatever they think is best for their patient."
Formularies operate within a clinical governance framework that is designed to support, not override, clinical judgement. Non-formulary prescribing is available in all health systems for patients where formulary options are clinically inappropriate — the process requires a documented clinical rationale, not blanket prohibition. The evidence base for managed formularies is strong: they reduce medication errors (by limiting the number of similar agents in use), improve adherence to best-practice guidelines, enable systematic medicines safety monitoring, and deliver cost savings that fund other patient care. The perceived tension between formularies and clinical autonomy is greatest when formulary decisions are poorly communicated — this is why prescriber engagement and transparent evidence-based decision-making are core competencies in formulary management.
Research & Outlook
Formulary management is being transformed by real-world data and AI-powered prescribing analytics that can identify formulary adherence patterns, flag high-cost non-formulary prescribing, and model the population-level impact of formulary changes with greater precision than traditional prescribing audits. The NHS's Getting It Right First Time (GIRFT) programme and Medicines Value Programme are driving systematic formulary harmonisation across ICBs, reducing the variation in medicines access that had previously existed across CCG boundaries. Personalised medicine and genomic prescribing are creating new formulary challenges: how to manage conditional approvals (e.g., for treatments restricted to specific biomarker-positive populations) and how to integrate companion diagnostic requirements into formulary governance frameworks.
See This Skill In Action
Watch a professional demonstrate Formulary Management in a real working environment — what it looks like, how it's applied, and why it matters.
Healthcare / Pharmacy
Formulary Management
Also Known As
Growth Path
Can review an individual NICE technology appraisal and summarise its implications for a formulary, with supervision. Understands the structure of a medicines formulary, the role of the Drug and Therapeutics Committee, and the difference between formulary and non-formulary medicines. Can extract and interpret basic prescribing data from ePACT2 or OpenPrescribing.
Independently prepares formulary submissions for the Medicines Management Committee, including clinical evidence review, cost-effectiveness analysis, and a structured recommendation. Monitors formulary adherence data and designs prescriber feedback interventions. Manages a therapeutic area of the formulary end-to-end.
Leads the medicines management committee secretariat or serves as chair. Develops formulary policy for an ICB or NHS Trust, including interface prescribing guidelines and area prescribing committee (APC) submissions. Manages complex formulary decisions involving unlicensed medicines, off-label use, and highly specialised technologies. Contributes to national medicines optimisation frameworks.
How to Practise
- 1.Complete the Royal Pharmaceutical Society (RPS) Foundation Pharmacy Framework or Faculty Advanced Pharmacist credentials, both of which include medicines optimisation and formulary management competencies.
- 2.Review a selection of published NICE technology appraisals and understand how clinical evidence (QALY analysis, clinical trial data, comparator arms) is translated into a formulary inclusion recommendation.
- 3.Attend or review minutes from a Medicines Management Committee or Drug and Therapeutics Committee (DTC) to understand the governance process through which formulary decisions are made, ratified, and communicated to prescribers.
- 4.Analyse prescribing data using OpenPrescribing.net (freely available NHS prescribing data at practice and ICB level) to identify prescribing patterns, assess formulary adherence, and spot opportunities for medicines optimisation.
How to Prove
- ·Formulary submissions prepared for a Medicines Management Committee — documented NICE appraisal review, cost-effectiveness analysis, and a recommendation with a rationale, progressed to a committee decision
- ·Prescribing analytics reports demonstrating measurable improvement in formulary adherence following an intervention — educational campaign, prescribing audit feedback, or therapeutic substitution programme
- ·Evidence of managing a formulary transition — implementing a NICE-mandated treatment or withdrawing a superseded medicine across a health system, with prescriber communication and monitoring data
- ·Contribution to a Joint Formulary (e.g., primary/secondary care interface formulary) — demonstrating cross-organisational medicines management work and formulary harmonisation